TP53 and neoplasm: Hormonal receptors for estrogen (ER) and progesterone (PgR), mutations of p53, mismatch repair (MMR) deficiency, and tumor-infiltrating lymphocytes (TILs), are considered promising markers for EC prognosis [1,12,13,14].